These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27626169)

  • 1. The putative oncotarget CSN5 controls a transcription-uncorrelated p53-mediated autophagy implicated in cancer cell survival under curcumin treatment.
    Zhang QY; Jin R; Zhang X; Sheng JP; Yu F; Tan RX; Pan Y; Huang JJ; Kong LD
    Oncotarget; 2016 Oct; 7(43):69688-69702. PubMed ID: 27626169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles for CSN5 in control of p53/MDM2 activities.
    Zhang XC; Chen J; Su CH; Yang HY; Lee MH
    J Cell Biochem; 2008 Mar; 103(4):1219-30. PubMed ID: 17879958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy.
    Pearce C; Hayden RE; Bunce CM; Khanim FL
    BMC Cell Biol; 2009 Apr; 10():31. PubMed ID: 19400951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
    Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
    Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of CSN5 promotes the apoptosis of gastric cancer cells through regulating p53-related apoptotic pathways.
    Sang MM; Du WQ; Zhang RY; Zheng JN; Pei DS
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2897-901. PubMed ID: 26048783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells.
    Bhansali M; Shemshedini L
    Mol Endocrinol; 2014 Jun; 28(6):834-45. PubMed ID: 24725084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.
    Adler AS; Littlepage LE; Lin M; Kawahara TL; Wong DJ; Werb Z; Chang HY
    Cancer Res; 2008 Jan; 68(2):506-15. PubMed ID: 18199546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
    Huang M; Xiong H; Luo D; Xu B; Liu H
    Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response.
    Lee YH; Judge AD; Seo D; Kitade M; Gómez-Quiroz LE; Ishikawa T; Andersen JB; Kim BK; Marquardt JU; Raggi C; Avital I; Conner EA; MacLachlan I; Factor VM; Thorgeirsson SS
    Oncogene; 2011 Oct; 30(40):4175-84. PubMed ID: 21499307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome.
    Calligé M; Kieffer I; Richard-Foy H
    Mol Cell Biol; 2005 Jun; 25(11):4349-58. PubMed ID: 15899841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The β-catenin E3 ubiquitin ligase SIAH-1 is regulated by CSN5/JAB1 in CRC cells.
    Jumpertz S; Hennes T; Asare Y; Vervoorts J; Bernhagen J; Schütz AK
    Cell Signal; 2014 Sep; 26(9):2051-9. PubMed ID: 24882689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.
    Mazzu YZ; Liao YR; Nandakumar S; Jehane LE; Koche RP; Rajanala SH; Li R; Zhao H; Gerke TA; Chakraborty G; Lee GM; Nanjangud GJ; Gopalan A; Chen Y; Kantoff PW
    Oncogene; 2022 Jan; 41(5):671-682. PubMed ID: 34802033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted inhibition of the COP9 signalosome for treatment of cancer.
    Schlierf A; Altmann E; Quancard J; Jefferson AB; Assenberg R; Renatus M; Jones M; Hassiepen U; Schaefer M; Kiffe M; Weiss A; Wiesmann C; Sedrani R; Eder J; Martoglio B
    Nat Commun; 2016 Oct; 7():13166. PubMed ID: 27774986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSN5 controls the growth of osteosarcoma via modulating the EGFR/PI3K/Akt axis.
    Wan Z; Huang S; Mo F; Yao Y; Liu G; Han Z; Chen M; Zhiyun L
    Exp Cell Res; 2019 Nov; 384(2):111646. PubMed ID: 31560888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial CSN5 impairs NF-κB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions.
    Asare Y; Shagdarsuren E; Schmid JA; Tilstam PV; Grommes J; El Bounkari O; Schütz AK; Weber C; de Winther MP; Noels H; Bernhagen J
    Thromb Haemost; 2013 Jul; 110(1):141-52. PubMed ID: 23636414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSN5/Jab1 controls multiple events in the mammalian cell cycle.
    Yoshida A; Yoneda-Kato N; Panattoni M; Pardi R; Kato JY
    FEBS Lett; 2010 Nov; 584(22):4545-52. PubMed ID: 20974137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer.
    Guo Z; Wang Y; Zhao Y; Shu Y; Liu Z; Zhou H; Wang H; Zhang W
    Gene; 2019 Mar; 687():219-227. PubMed ID: 30468907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
    Mao L; Le S; Jin X; Liu G; Chen J; Hu J
    Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSN5 Promotes Carcinogenesis of Thyroid Carcinoma Cells Through ANGPTL2.
    Xie P; Wang H; Fang J; Du D; Tian Z; Zhen J; Liu Y; Ding Y; Fu B; Liu F; Huang D; Yu J
    Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33508120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deubiquitination and Stabilization of PD-L1 by CSN5.
    Lim SO; Li CW; Xia W; Cha JH; Chan LC; Wu Y; Chang SS; Lin WC; Hsu JM; Hsu YH; Kim T; Chang WC; Hsu JL; Yamaguchi H; Ding Q; Wang Y; Yang Y; Chen CH; Sahin AA; Yu D; Hortobagyi GN; Hung MC
    Cancer Cell; 2016 Dec; 30(6):925-939. PubMed ID: 27866850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.